Taiwan Advance Bio-Pharmaceutical Inc. (TPEX:4186)
Taiwan · Delayed Price · Currency is TWD 10.15
-0.05 (-0.49%)
Jun 18, 2026, 2:39 PM CST
TPEX:4186 Market Cap
TPEX:4186 has a market cap or net worth of 913.5 million as of June 18, 2026. Its market cap has decreased by -27.50% in one year.
Market Cap
913.50M
Enterprise Value
1.04B
Revenue
364.79M
Ranking
n/a
PE Ratio
32.74
Stock Price
10.15
Market Cap Chart
Since November 27, 2012, TPEX:4186's market cap has decreased from 4.10B to 913.50M, a decrease of -77.71%. That is a compound annual growth rate of -10.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 913.50M | -8.97% |
| Dec 31, 2025 | 1.00B | -29.21% |
| Dec 31, 2024 | 1.42B | -4.55% |
| Dec 29, 2023 | 1.49B | -6.78% |
| Dec 30, 2022 | 1.59B | -4.84% |
| Dec 30, 2021 | 1.67B | -26.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LabTurbo Biotech | 1.09B |
| Lukas Biomedical | 1.08B |
| Holy Stone Healthcare | 1.06B |
| Level Biotechnology | 1.02B |
| GeneReach Biotechnology | 991.34M |
| TCI GENE | 978.96M |
| U-Neuron Biomedical | 973.67M |
| Meribank Biotech | 910.81M |